Your browser doesn't support javascript.
loading
Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription.
Zhao, Tingting; Sun, Zhengyu; Lai, Xueli; Lu, Hongtao; Liu, Lulu; Li, Shuangxi; Yuan, Ji-Hang; Guo, Zhiyong.
Afiliação
  • Zhao T; Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Sun Z; Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200433, China.
  • Lai X; Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Lu H; Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Liu L; Department of Nutrition, Naval Medical University, Shanghai, 200433, China.
  • Li S; Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Yuan JH; Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, 200433, China.
  • Guo Z; Department of Medical Genetics, Naval Medical University, Shanghai, 200433, China. jihangyuan@smmu.edu.cn.
J Transl Med ; 21(1): 614, 2023 09 11.
Article em En | MEDLINE | ID: mdl-37697303
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peritônio / Tamoxifeno / Fibrose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peritônio / Tamoxifeno / Fibrose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China